Programme 14 February

Graphics Norway Life Science 14 February.

09:00–10:15 Plenary Session

Health Data and Public Private Partnerships - How Competitive is Norway?

Inspired of what Finland has achieved in form of public private partnerships based on its data lakes, this session will address the pitfalls and opportunities for research and analysis on Norwegian data sources. We will also discuss the Nordic position as a leading region for health data research and use.

Part 1 Look to Finland

Matthew Iles, AbbVie.P?ivi Sillanaukee, Special Envoy for Health & Well-being, Ministry for Social Affairs and Health, Finland.Tero Ylisaukko-oja, MedEngine.
Keynote by

  • Matthew Iles, General Manager, AbbVie Scandinavia:
    The Finnish infrastructure for health data research

Dialogue: The Critical Elements in the Finnish infrastructure to be attractive for academia and industry

  • P?ivi Sillanaukee, Special Envoy for Health & Well-being of Finland at the Ministry for Social Affairs and Health
  • Tero Ylisaukko-oja, CEO and Founder MedEngine
  • Matthew Iles, General Manager, AbbVie Scandinavia
     

Part 2 Opportunities in Norway

Matthias Kolberg, Oslo University HospitalImage may contain: Cheek, Gesture, Eyelash, Smile, Fashion accessory.

  • Matthias Kolberg, Special Advisor, Oslo University Hospital: Research biobanks at Oslo University Hospital   ?

  • Gun Peggy Knudsen, Acting Director General, Norwegian Institute of Public Health (FHI): The national health registries
     

Part 3 Panel discussion: What can we learn from Finland? The way forward

State Secretary Ellen R?nning-Arnesen.Per Morten SandsetGun Peggy Knudsen, Acting Director General, Norwegian Institute of Public Health.Steinar Thoresen.P?ivi Sillanaukee, Special Envoy for Health & Well-being, Ministry for Social Affairs and Health, Finland.P?l Hasvold, AstraZeneca.

  • Ellen R?nning-Arnesen, State Secretary, Ministry of Health and Care Services, Labour Party
  • Per Morten Sandset, Vice-Rector for Research and Innovation, University of Oslo
  • Gun Peggy Knudsen, Acting Chief Executive Officer, Norwegian Institute of Public Health
  • Steinar Thoresen, Medical director, Nordic RWE 
  • P?ivi Sillanaukee, Special Envoy for Health & Well-being of Finland at the Ministry for Social Affairs and Health

Moderator: P?l Hasvold, Medical Evidence Head, AstraZeneca

Event organizer: LMI (Association of Pharmaceutical Industry in Norway)

10:15–10:45 Break

10:45–12:15 Plenary Session

Attracting investments and talents to build Norway’s Life Science Industry

This session will discuss what global industry leaders are looking for when they are investing, how to cooperate strategically in the global competition for investments and give concrete examples of strong investments areas in Norway.


How do we attract investments to Norway?

Jan Christian Vestre, Minister of Trade and Industry.
Photo Vestre: NTB Kommunikasjon / Office of the Prime Minister

Keynote by

Follow the Science - Making the case for Norwegian Research and Innovation

Hilde Nebb, UiO Growth House.Alexandra Bech Gj?rv, SINTEF.Kjetil Tasken, Oslo University Hospital.
Photo: Alexandra Bech Gj?rv:Terje Trobe/SINTEF

Speaker

Attracting Talent and Investments

?yvind S?tvedt, City of OsloRasmu Figenschou, DNB.
Speakers

  • ?yvind S?tvedt, Assistant Director General and Head of Business Development, Department for Culture and Business Development, City of Oslo?
  • Rasmus Figenschou, EVP Business Banking Norway, DNB

Team Nordic – a case example

Presentation of a recently concluded Nordic collaboration project within health start-ups. The partners (to be revealed) will present the purpose and content of the agreement.


Stronger together - Building global partnerships through Nordic cooperation

Henrik Ullum. Hanne Mette Dyrlie Kristensen, The Life Science Cluster.Johanna Liden, AstraZeneca.Anette Steenberg.

A dialogue with

  • Henrik Ullum, CEO, Statens Serum Institut, Denmark
  • Hanne Mette Dyrlie Kristensen, CEO, The Life Science Cluster  
  • Johanna Lidén, Director of Nordic and Sweden Medical and Regulatory Affairs, AstraZeneca     
  • Anette Steenberg, CEO, Medicon Valley Alliance          

Moderators: Idar Kreutzer, Area Director, NHO and Filippa Kull, Business Development Director, Stockholm Science City

Idar Kreutzer, NHO.Filippa Kull, Stockholm Science City.


Event organizer: The Life Science Cluster, UiO Growth House, Norway Health Tech, Oslo Science City and LMI (Association of Pharmaceutical Industry in Norway) 

 

10:45–12:15 Young Talents Inspirational Talks

Go to programme

12:15–13:15 Lunch

13:15–14:45 Afternoon Sessions

Health data for better and more sustainable patient care

This session will have two parts. Part one will focus on health data in clinical trials and for monitoring impact, while part two focuses on unlocking the potential of health data from patient records.
 

Young Talents Network Meetings 


You will have the opportunity to meet representatives from companies. 

Note that you need to register for Network meetings in order to attend (same registration form).

Go to the programme

Pitching Session

Join when startup companies and innovation projects pitch their business idea. 

  • Hemispherian Adam Robertson, Chief Scientific Officer
  • "Novel vaccine platform for animal health" Hanne Winther Larsen, Professor Institute of Pharmacy, University of Oslo
  • "RNA-DEGRA" Francis Combes, Research Scientist SINTEF

  • GreinDx Ove Solesvik, CEO and Co-Founder

  • Adjutec Pharma Bj?rn Klem, CEO

  • "TREM2-agonist for Alzheimer’s disease therapy" Lars Nilsson, Professor, Dept. Pharmacology, University of Oslo

Panel: 

  • Terje Ahlquist, Nordic Medical Director, AstraZeneca
  • Hilde Medb?e, Healthcare Solutions Manager, Novartis
  • Kirsti Nyhus, Country Manager, AbbVie

Host: Morten Egeberg, Leader SPARK Norway and Administrative Leader UiO:Life Science

Programme other days